STA®-Liatest® D-Di Plus, Less interferences for even More Confidence
As part of Stago's continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous ThromboEmbolism (VTE).
Read more
CY-QUANT VASP/P2Y12: A new kit to make VASP testing more accessible
According to peer-reviewed literature, VASP is the most specific biomarker of P2Y12 receptor inhibition. Unlike other assays currently on the market, it is not interfered by aspirin, P2Y1, anti-GPIIb-IIIa drugs, VWF level and platelet count. With more than 1,000 publications, VASP is validated and suitable for testing utilising all anti-P2Y12 drugs currently on the market and in development.
Read more
STA®-Liquid Fib is the lastest innovation in our routine line. This new liquid reagent for the quantitative determination of fibrinogen levels is based on the reference Clauss clotting method combined with the mechanical clot detection system. STA®-Liquid Fib is a practical and robust reagent designed to give reliable results.
Read more
Megamix Line: Expand the limits of MP analysis with 2 new products
In addition to functional assays currently available at Stago (STA®-Procoag PPL and CAT) Megamix products are two new tools designed for standardising Microparticle (MP) quantitative analysis by flow cytometry. These products assist in the process of setting-up a standardised MP gate to ensure a good inter-instrument and inter-lab reproducibility. They are also used as a day-to-day QC to check instrument consistency.
Read more
STA Compact Max®: Innovation born from Expertise
STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.
Read more